Ordentlich Peter's Form 4 filing
Syndax Pharmaceuticals Inc (SNDX) · filed Aug 26, 2022
- Accession no.
- 0001562180-22-006334
- Filed
- Aug 26, 2022
- Trade date
- Jul 29-Aug 24, 2022
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $626.0K. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ordentlich PeterCIK 0001594274 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2022 | Common Stock | JOtherAcquired | +265 | $14.12 | +$3,741.8 | 265 | Direct | |
| Aug 24, 2022 | Common Stock | MOption exerciseAcquired | +22,846 | $6.32 | +$144,386.72 | 23,111 | Direct | |
| Aug 24, 2022 | Common Stock | SSaleDisposed | −22,846 | $25.04 | −$572,063.84 | 265 | Direct | |
| Aug 24, 2022 | Common Stock | MOption exerciseAcquired | +2,154 | $6.35 | +$13,677.9 | 2,419 | Direct | |
| Aug 24, 2022 | Common Stock | SSaleDisposed | −2,154 | $25.04 | −$53,936.16 | 265 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2022 | Common Stock | MOption exerciseDisposed | −2,154 | $0.00 | $0 | 0 | Direct | |
| Aug 24, 2022 | Common Stock | MOption exerciseDisposed | −22,846 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.